In glioma, TFAP2A disturbs the expression of stemness-related genes, such as NANOG, SOX2 and CD133, via both directly binding the regulation region of NANOG and indirectly interfering with the IL6/JAK2/STAT3 signaling pathway [48]. Here, TFAP2A is linked to central nervous system cancer.